Antoniou KM, Distler O, Gheorghiu AM, Moor CC, Vikse J, Bizymi N, Galetti I, Brown G, Bargagli E, Allanore Y, Corte TJ, Dieudé P, Cottin V, Fisher BA, Fabre A, Giles JT, Kreuter M, Lundberg IE, Poletti V, Maurer B, Renzoni EA, Müller-Ladner U, Strek ME, Sverzellati N, Studenic P et al. (2026)
ERS/EULAR clinical practice guidelines for connective tissue disease-associated interstitial lung disease
Eur Respir J, 67 (1)
DOI 10.1183/13993003.02533-2024, PubMed 40907995

Burja B, Boubaya M, Bruni C, Christ L, Ananyeva LP, Atzeni F, Bergmann C, Carreira PE, De Vries-Bouwstra J, Papa ND, Marcoccia A, Masado O, Riemekasten G, Rosato E, Schmeiser T, Sprecher M, Hoffmann-Vold AM, Kollert F, Guler S, Distler O, Elhai M, EUSTAR collaborators (2026)
Anti-Ro/SSA and rheumatoid factor antibodies are associated with more severe lung involvement in patients with systemic sclerosis: a study from the EUSTAR database
Eur J Intern Med, 106898 (in press)
DOI 10.1016/j.ejim.2026.106898, PubMed 42191555

Campochiaro C, Truchetet ME, Vonk M, De Luca G, Cuomo G, Ananieva LP, Hachulla E, Smith V, Gheorghiu AM, Becvar R, Carreira P, Hunzelmann N, Furst DE, Ortiz-Santamaria V, Del Galdo F, Matucci-Cerinic M, Hoffmann-Vold AM, EUSTAR collaborators (2026)
Impact of Evolving Treatment Patterns on Interstitial Lung Disease Progression in Systemic Sclerosis Using the European Scleroderma Trials and Research Database
Arthritis Rheumatol (in press)
DOI 10.1002/art.70043, PubMed 41568546